MedTrace Logo

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

NCT01497379 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-03-29

No results posted yet for this study

Summary

Patients who are legally blind, caused by retinal degeneration of photoreceptor rods \& cones (e.g. Retinitis pigmentosa), receive a subretinal implant to restore vision partially.

Conditions

Interventions

PROCEDURE

surgical implantation of subretinal device

surgical implantation of subretinal device

PROCEDURE

surgical implantation of subretinal device

intra-individual implant OFF

Sponsors & Collaborators

  • Retina Implant AG

    lead INDUSTRY

Principal Investigators

  • David Wong, Prof., MD · Chair Professor in Ophthalmology Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-01-31
Completion
2015-01-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01497379 on ClinicalTrials.gov